arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

DarioHealth Corp.

DRIO
$6.84 0.00 (0.00%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
62 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

DarioHealth Corp. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $63.9M
Dividend Yield
Revenue Growth -3.6%
Op. Margin -125.1%
ROIC -7.8%
FCF / Share $-0.66
Trailing P/E 8.1x
Price / Book 0.9x
FCF Yield
Debt / Equity 0.56
info Valuation on last close. End-of-day price, Sep 23, 2026.

62-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.18M
↓ -3.6%
Net Income Profit after all expenses
$-7.92M
↑ +39.0%
Operating Margin Operating profit as % of sales
-125.1%
↑ +4.4% 1th
FCF / Share Free cash flow per share
$-0.66
↑ +28.8%
Long-Term Debt Long-term obligations
$31.06M
— +0.4%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
14
Financial Health
42
Cash Quality
45

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 15 years · 62 quarters